135.40CHF+0.15%Mkt Cap: 2.70B CHFP/E: 30.84Last update: 2026-05-13
Medacta Group SA develops, manufactures, and distributes orthopedic and neurosurgical medical devices Latin America, North America, the Asia-Pacific, and Middle East and Africa. It offers personalized 3D planning tools f…
Industry Peers
Medical Devicesloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)30.84
P/E (Forward)25.10
PEG—
P/B6.54
P/S4.03
EV/EBITDA17.37
EV/Revenue4.37
EPS (TTM)4.39
EPS (Forward)5.51
Cash Flow & Leverage
FCF Yield-1.25%
FCF Margin-4.91%
Operating CF152.65M CHF
CapEx (TTM)143.10M CHF
Net Debt/EBITDA1.34
Net Debt229.56M CHF
Technical
SMA 50150.51 (-10.0%)
SMA 200152.35 (-11.1%)
Beta1.00
S&P 52W Chg24.23%
Avg Vol (30d)13.46K
Avg Vol (10d)17.68K
Technical Indicators
RSI (14)31.1
MACD-4.7869
MACD Signal-3.5666
MACD Hist.-1.2202
BB Upper165.20 CHF
BB Middle146.94 CHF
BB Lower128.68 CHF
BB Width24.86%
ATR (14)4.082 CHF
Vol Ratio (20d)0.86x
52W Range
128.0015% of range177.20
52W High177.20 CHF
52W Low128.00 CHF
Profitability
Gross Margin67.07%
EBITDA Margin25.13%
Profit Margin13.96%
Oper. Margin15.96%
ROE20.91%
ROA10.40%
Revenue Growth12.50%
Earnings Growth1.20%
Balance Sheet
Debt/Equity0.57
Current Ratio2.08
Quick Ratio0.77
Book Value/Sh21.15 CHF
Cash/Share1.668 CHF
Dividends
Fwd Div Rate1.100 CHF
Trail. Div Rate1.181 CHF
Div. Yield0.79%
5Y Avg Yield—
Payout Ratio15.48%
Ex-Div DateMay 7, 2026
Pay DateMay 13, 2025
Ownership
Shares Out.19.91M
Float—
Insiders69.66%
Institutions18.24%
Analyst Consensus
Rating—
Target (Mean)178.54 CHF
Target Range146.63 CHF – 199.18 CHF
# Analysts5
Company
Market Cap2.70B CHF
Enterprise Value2.99B CHF
Revenue (TTM)683.83M CHF
Gross Profit458.66M CHF
Net Income (TTM)95.46M CHF
Revenue/Share34.32 CHF
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees2.0K
Last Price135.40 CHF
CountryCH
SectorHealthcare
IndustryMedical Devices
ISINCH0468525222